CXCL8 and cancer: Examination of a panel of tumor cell lines revealed that invasive tumor cells express higher levels of the IL-8 receptor CXCR2 than noninvasive cancer cells and IL-8 stimulation increases tumor cell cytoskeletal remodeling and traction forces which may impact endothelial cell-cell junction breakdown during metastasis [29].